Abiopharma

Indaptus Therapeutics Notification (INDP)

Indaptus Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar

Bluejay Diagnostics Announces Completion of Commercial-Scale IL-6 Antibody Production

EUDA Health to Launch EUDA Helixé 2.0 in January 2026

Henry Schein to Participate in the J.P. Morgan Conference in January

Greenwich LifeSciences Extends Lock-up of Directors and Officers to September 30, 2026

ITGR Investors Have Opportunity to Lead Integer Holdings Corporation Securities Fraud Lawsuit with the Schall Law Firm

Inspire Medical Systems, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - INSP

INSP Investors Have Opportunity to Lead Inspire Medical Systems, Inc. Securities Fraud Lawsuit with the Schall Law Firm

[Press Release] HUTCHMED Announces NDA Acceptance in China with Priority Review Status for Fanregratinib in Intrahepatic Cholangiocarcinoma